Friday, July 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 3 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 12364708

    Injectable scaffold for treatment of intracranial aneurysms and related technology

    Covidien LP · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  2. US 12365719

    CD80 extracellular domain polypeptides and their use in cancer treatment

    Five Prime Therapeutics, Inc. · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  3. US 12364683

    Non-sedating dexmedetomidine treatment regimens

    BioXcel Therapeutics, Inc. · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  4. US 12364765

    Pegylated cystathionine beta synthase for enzyme therapy for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  5. US 12359178

    Methods and compositions for treatment of hunter syndrome comprising iduronate-2-sulfatase

    Takeda Pharmaceutical Company Limited · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  6. US 12357598

    Treatment of neurodevelopmental disorders

    The Regents of the University of California · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  7. US 12358909

    Capsazepine analogs for the treatment of cancer and other proliferative diseases

    The Board of Regents of the University of Texas System · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  8. US 12358968

    Utilization of CD39 and CD103 for identification of human tumor reactive T cells for treatment of cancer

    Providence Health & Services—Oregon · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  9. US 12357604

    Topical formulations of cannabinoids and use thereof in the treatment of pain

    INMED PHARMACEUTICALS INC. · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  10. US 12357615

    Compositions for the treatment of brain tumors

    United States Government as represented by the Department of Veterans Affairs · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  11. US 12357586

    Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy

    JAZZ PHARMACEUTICALS RESEARCH UK LIMITED · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  12. US 12350262

    Methods of treatment for cystic fibrosis

    Vertex Pharmaceuticals Incorporated · Granted Jul 8, 2025 · Expires Jul 3, 2045

    granted
  13. US 12351560

    Next generation FKBP52 targeting drugs for the treatment of prostate and breast cancer

    The Board of Regents of the University of Texas System · Granted Jul 8, 2025 · Expires Jul 3, 2045

    granted
  14. US 12350258

    Compositions and methods for treatment of skin-related diseases and promoting dermatological health

    Script Essentials, LLC · Granted Jul 8, 2025 · Expires Jul 3, 2045

    granted
  15. US 12351834

    Compositions and methods for the treatment of ornithine transcarbamylase deficiency

    ARCTURUS THERAPEUTICS, INC. · Granted Jul 8, 2025 · Expires Jul 3, 2045

    granted
  16. US 12351609

    Use of a small native peptide activator of SERCA pump for treatment of heart failure and other disorders characterized by cytosolic calcium overload

    The Board of Regents of the University of Texas System · Granted Jul 8, 2025 · Expires Jul 3, 2045

    granted
  17. US 12351877

    Systems and methods for determining a treatment course of action

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jul 8, 2025 · Expires Jul 3, 2045

    granted
  18. US 12350253

    Use of cannabinoids in the treatment of dyskinesia associated with parkinson's disease

    JAZZ PHARMACEUTICALS RESEARCH UK LIMITED · Granted Jul 8, 2025 · Expires Jul 3, 2045

    granted
  19. US 12343448

    Use of stem cells produced by stem cell generator in treatment of hematopoietic damage

    East China University of Science and Technology · Granted Jul 1, 2025 · Expires Jun 26, 2045

    granted
  20. US 12343350

    Istaroxime-containing intravenous formulation for the treatment of acute heart failure (AHF)

    Windtree Therapeutics, Inc. · Granted Jul 1, 2025 · Expires Jun 26, 2045

    granted
  21. US 12344665

    Treatment of fibrodysplasia ossificans progressiva by administration of an anti-activin a antibody

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 1, 2025 · Expires Jun 26, 2045

    granted
  22. US 12338437

    OPA1 antisense oligomers for treatment of conditions and diseases

    STOKE THERAPEUTICS, INC. · Granted Jun 24, 2025 · Expires Jun 19, 2045

    granted
  23. US 12337033

    Encapsulated glycolipid antigens for treatment of neoplastic diseases

    EnGeneIC Molecular Delivery Pty Ltd · Granted Jun 24, 2025 · Expires Jun 19, 2045

    granted
  24. US 12336990

    Treatment of prostate cancer

    Takeda Pharmaceutical Company Limited · Granted Jun 24, 2025 · Expires Jun 19, 2045

    granted